Coronavirus India LIVE Updates – At the jumbo facility in Pune on Wednesday. (Photo by Arul Horizon)
Coronavirus India LIVE updates:
Clearing the way for NEET and JEE (Main), the Supreme Court on Friday dismissed a series of petitions, including one filed by ministers from six opposition-ruled states, seeking a revision of their Aug. 17 order allowing for entrance exams for doctors and engineering. courses to take.
Global food price inflation is back in positive territory. This is not bad news for Indian farmers ahead of the harvest season for kharif crops, even as agriculture is the only sector that has grown 3.4% YoY (YoY) in April-June amidst the contraction of the general economy by 22.8 percent.
The Food and Agriculture Organization of the United Nations Food Price Index (FPI) averaged 96.1 points in August, increasing for the third consecutive month, from 91 in May, 93.1 in June and 94, 3 in July. Annual food inflation based on the world index (base year: 2014-16 = 100) stood at 2.24%, compared to -1.23% in April, -3.40% in May, the -2.31% in June and -0.85%. cent in July.
International food prices have been very volatile for almost a year. Between August 2019 and January 2020, inflation based on the FPI soared from -1.99% to 9.94% (see graph). The index itself touched 102.5 points in January, the highest since December 2014, reflecting the shortage of supply that is accumulating in many commodities, from palm oil and sugar to rice and milk. skimmed powder (LDP), after a prolonged period of low performance by producers.
The race to produce a coronavirus vaccine has now turned into a race to produce it before the November 3 US presidential election. All the discussion about vaccines now centers on the question of whether a vaccine can be available, even theoretically, before then.
The events of the past few days suggest that, in America at least, that was the goal everyone was working towards.
On Thursday, Pfizer, one of the main contenders to produce the vaccine, said it expected to obtain the effectiveness data from the ongoing phase 3 trials by the end of October, and that if the results were satisfactory, it would act immediately to seek authorization. FDA emergency use.
.
